Interplay Learning secures third appearance on Inc. 5000
The immersive learning company ranks No. 1379 on prestigious list, signifying meaningful business growth AUSTIN, Texas, Aug. 12, 2025 /PRNewswire/ — Interplay... Read more.
Acurx Pharmaceuticals, Inc. Reports Second Quarter Results and Provides Business Update
STATEN ISLAND, N.Y., Aug. 12, 2025 /PRNewswire/ — Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”), a late-stage... Read more.
Verifiable Named to 2025 Inc. 5000 List of Fastest-Growing Private Companies in America
AUSTIN, Texas, Aug. 12, 2025 /PRNewswire/ — Inc. magazine today revealed that Verifiable, the industry-leading healthcare credentialing and monitoring platform,... Read more.
Canada Secures Sovereign Path to Orbit: Maritime Launch and Reaction Dynamics Sign Pathfinder Agreement to Establish Domestic Orbital Launch Capability
Maritime Launch Services and Reaction Dynamics have signed a pathfinder launch agreement, marking a major step forward in securing Canada’s sovereign access... Read more.
Daqo New Energy to Announce Unaudited Results for the Second Quarter of 2025 on August 26, 2025
SHANGHAI, Aug. 12, 2025 /PRNewswire/ — Daqo New Energy Corp. (NYSE: DQ) (“Daqo New Energy” or the “Company”), a leading manufacturer... Read more.
Compass Datacenters Ranks No. 982 on the 2025 Inc. 5000 List of America’s Fastest-Growing Private Companies
With three-year revenue growth of 435%, this marks Compass Datacenter’s Fifth Time on the List NEW YORK, Aug. 12, 2025 /PRNewswire/ — Inc. today announced... Read more.
NetDocuments Climbs 329 Places to Secure Spot on 2025 Inc. 5000 List of America’s Fastest-Growing Private Companies
Fourth consecutive year of recognition highlights company’s sustained growth and legal tech innovation. LEHI, Utah, Aug. 12, 2025 /PRNewswire/ — Today,... Read more.
CalciMedica Reports Second Quarter 2025 Financial Results and Provides Clinical & Corporate Updates
Enrollment ongoing in Phase 2 KOURAGE trial of Auxora™ in acute kidney injury (AKI) with respiratory failure; data expected in early 2026 Productive initial... Read more.
Abcentra LLC Announces First Patient Dosed in Phase 2b “FORTIFY” Clinical Trial Evaluating Orticumab in Patients with Cardiovascular Disease
LOS ANGELES, Aug. 12, 2025 /PRNewswire/ — Abcentra LLC, a clinical-stage biopharmaceutical company pioneering targeted therapies for cardiovascular inflammation,... Read more.
accessiBe Recognized on the 2025 Inc. 5000 List of America’s Fastest-Growing Private Companies
New York-based Web Accessibility Software Provider Recognized for Rapid Growth NEW YORK, Aug. 12, 2025 /PRNewswire/ — Inc., the leading media brand and playbook... Read more.